- Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
-
Trinh H, Irish V, Diaz M, Atiemo H
- KMID: 2460735
- Int Neurourol J.
- 2019 Sep;23(3):226-233.
- doi: 10.5213/inj.1938030.015
PURPOSE: Intradetrusor onabotulinum toxin A (BTXA) and sacral neuromodulation (SNM) are effective third-line therapies for overactive bladder (OAB). We aimed to measure the outcomes of BTXA for treatment of OAB... -
- CITED
-
- Close
- SHARE
-
- Close
